Pluri (PLUR) Total Liabilities (2011 - 2025)
Pluri (PLUR) reported Total Liabilities of $45.2 million for Q4 2025, up 33.83% year-over-year from $33.8 million in Q4 2024, and up 14.97% quarter-over-quarter from $39.3 million in Q3 2025.
Pluri (PLUR) Total Liabilities (2011 - 2025) Analysis & Trends
Pluri (PLUR) has 15 years of Total Liabilities data on file, last reported at $45.2 million in Q4 2025.
- Total Liabilities for Q4 2025 came in at $45.2 million, up 33.83% year-over-year; the trailing twelve-month figure through Dec 2025 was $45.2 million (up 33.83% YoY), and the FY2025 annual result was $39.5 million, up 15.94% from the prior year.
- Total Liabilities grew to $45.2 million in Q4 2025 per PLUR's latest filing, from $39.3 million in the prior quarter.
- Over five years, Total Liabilities peaked at $45.2 million in Q4 2025 and troughed at $11.0 million in Q1 2021.
- A 5-year average of $35.2 million and a median of $35.4 million in 2023 frame the typical range for Total Liabilities.
- The sharpest annual moves came in 2021 and 2022: Total Liabilities soared 285.82% in 2021, then dropped 15.44% in 2022.
- A 5-year view of Total Liabilities shows it stood at $41.3 million in 2021, then retreated by 15.44% to $35.0 million in 2022, then fell by 0.04% to $34.9 million in 2023, then decreased by 3.35% to $33.8 million in 2024, then soared by 33.83% to $45.2 million in 2025.
- Business Quant data shows PLUR's Total Liabilities at $45.2 million in Q4 2025, $39.3 million in Q3 2025, and $39.5 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | 1.74 Mn |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | 15.48 Mn |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | 16.35 Mn |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 731.60 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | 19.51 Mn |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | 10.44 Mn |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | 943,068.00 |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 7.12 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | 137.56 Mn |
| 10 | Pluri | 21.39 Mn | 21.87 Mn | 86,000.00 | 45.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 45.20 Mn |
| Sep 30, 2025 | 39.32 Mn |
| Jun 30, 2025 | 39.55 Mn |
| Mar 31, 2025 | 36.92 Mn |
| Dec 31, 2024 | 33.78 Mn |
| Sep 30, 2024 | 35.51 Mn |
| Jun 30, 2024 | 34.11 Mn |
| Mar 31, 2024 | 34.55 Mn |
| Dec 31, 2023 | 34.95 Mn |
| Sep 30, 2023 | 33.50 Mn |
| Jun 30, 2023 | 35.50 Mn |
| Mar 31, 2023 | 35.36 Mn |
| Dec 31, 2022 | 34.96 Mn |
| Sep 30, 2022 | 32.85 Mn |
| Jun 30, 2022 | 35.88 Mn |
| Mar 31, 2022 | 38.98 Mn |
| Dec 31, 2021 | 41.34 Mn |
| Sep 30, 2021 | 34.84 Mn |
| Jun 30, 2021 | 36.39 Mn |
| Mar 31, 2021 | 11.04 Mn |